Scrip 100: What It Takes To Sell $724bn-Worth Of Drugs
This article was originally published in Scrip
The Scrip 100 is a story of fallers and risers and a changing helicopter view of the pharmaceutical industry. Data alone cannot predict individual transactions or the fates of particular pharmaceutical products. However, they do paint a clear picture of the nature of the industry and the commercial environment that companies face.
Register for our free email digests: